Mavencare Inc. – Trademark Portfolio
Entity Type: 03
Mavencare Inc. has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as MAVENCARE and CONNECTED HOME CARE. Filings span 4 Nice Classification classes, with the highest activity in Class 42 (Computer & Scientific) and Class 9 (Computers & Electronics). This trademark owner is based in Toronto, Ontario.
20 Eglinton Avenue West, Suite 1111
Toronto, Ontario M4R1K8 , CA
Showing of trademarks Trademarks
Trademark Classifications
Mavencare Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Mavencare Inc. have?
Mavencare Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does Mavencare Inc. file in?
Mavencare Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 45 (Legal & Security Services), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Mavencare Inc.'s most well-known trademarks?
Mavencare Inc.'s registered trademark portfolio includes well-known marks such as MAVENCARE and CONNECTED HOME CARE. These are among 2 currently registered trademarks in the portfolio.
What is Mavencare Inc.'s trademark registration success rate?
Mavencare Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.